Decapping and 5′ to 3′ exonucleocytic degradation limits bunyavirus and flavivirus infections, with the decapping activator helicase DDX6 identified as an antiviral factor in both cases (37, 38). This evidence concerns the gene DDX6 and Flavivirus Infections.